| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699876 | Clinical Oncology | 2006 | 8 Pages |
Abstract
In our initial experience, compensator-based IMRT is feasible with regard to target coverage and parotid volume sparing. The parotid volume dose has significant clinical implications on the grade of xerostomia. Our results invoke rethinking into the issues of the parotid volume dose constraint in our subpopulation.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Nangia, K.S. Chufal, V. Arivazhagan, P. Srinivas, A. Tyagi, D. Ghosh,